Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 401 entries
View as:

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT05596981 Org: User:
Start: 10/01/22 End: 12/31/24 Due: 12/31/25

Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07031258 Org: User:
Start: 06/30/25 End: 06/30/27 Due: 06/30/28

Effect of Chemotherapy vs No Chemotherapy Pre-transplant to MDS Undergoing Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT02850822 Org: User:
Start: 07/31/16 End: 06/30/20 Due: 06/30/21

Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort

Phase: N/A Priority: Normal
NCT ID: NCT06443086 Org: User:
Start: 06/15/24 End: 12/30/24 Due: 12/30/25

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Phase: N/A Priority: Normal
NCT ID: NCT02240992 Org: User:
Start: 09/30/14 End: 12/31/18 Due: 12/31/19

A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure

Phase: N/A Priority: Normal
NCT ID: NCT05875649 Org: User:
Start: 07/02/23 End: 12/20/27 Due: 12/20/28

Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT05601479 Org: User:
Start: 11/01/22 End: 12/31/24 Due: 12/31/25

Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05659290 Org: User:
Start: 01/31/23 End: 12/31/25 Due: 12/31/26

G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT05453552 Org: User:
Start: 07/01/22 End: 12/31/24 Due: 12/31/25

The 3D Reconstruction Research of Pelvic Organ Prolapse Disease

Phase: N/A Priority: Normal
NCT ID: NCT03146195 Org: User:
Start: 09/30/16 End: 12/31/21 Due: 12/31/22

A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis

Phase: N/A Priority: Normal
NCT ID: NCT06308328 Org: User:
Start: 04/01/24 End: 01/31/27 Due: 01/31/28

HBsAg Declined Patients Follow-up Study

Phase: N/A Priority: Normal
NCT ID: NCT05977283 Org: User:
Start: 05/11/23 End: 03/31/28 Due: 03/31/29

Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT03023436 Org: User:
Start: 01/31/16 End: 06/30/22 Due: 06/30/23

A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease

Phase: N/A Priority: Normal
NCT ID: NCT06376201 Org: User:
Start: 04/30/24 End: 09/30/25 Due: 09/30/26

Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04221516 Org: User:
Start: 01/01/20 End: 02/01/24 Due: 02/01/25

Longitudinal Surveillance of Rectal Colonization and Transmission by Resistant Bacteria in Acutely Decompensated Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06511492 Org: User:
Start: 07/25/24 End: 08/01/26 Due: 08/01/27

Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03331211 Org: User:
Start: 11/01/17 End: 09/01/19 Due: 09/01/20

The Outcome of Chronic Kidney Disease Patients With Obstructive Sleep Apnea Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06971874 Org: User:
Start: 05/15/25 End: 12/31/29 Due: 12/31/30

Prospective Cohort Study of Complications and Outcomes in Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT06374511 Org: User:
Start: 01/01/24 End: 12/31/25 Due: 12/31/26

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

Phase: N/A Priority: Normal
NCT ID: NCT01763099 Org: User:
Start: 01/31/13 End: 01/31/16 Due: 01/31/17

Vitro Study of Tigecycline to Treat Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02883036 Org: User:
Start: 09/30/16 End: - Due: -

A Cross-sectional Study on the Correlation Between Screen Usage and Sleep and Cognition in Medical Students

Phase: N/A Priority: Normal
NCT ID: NCT06969599 Org: User:
Start: 05/15/25 End: 05/01/26 Due: 05/01/27

Safety and Efficacy of Amlotinib in the Treatment of Recurrent Craniopharyngioma

Phase: N/A Priority: Normal
NCT ID: NCT06970145 Org: User:
Start: 04/25/25 End: 04/20/28 Due: 04/20/29

MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD

Phase: N/A Priority: Normal
NCT ID: NCT02241018 Org: User:
Start: 09/30/14 End: 12/31/18 Due: 12/31/19

Time Restricted Feeding on Nonalcoholic Fatty Liver Disease ( TREATY-FLD )：a 12-month Follow-up Study

Phase: N/A Priority: Normal
NCT ID: NCT04988230 Org: User:
Start: 07/30/21 End: 12/30/21 Due: 12/30/22